Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61


Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment.

Rothberg JM, Sameni M, Moin K, Sloane BF.

Biochim Biophys Acta. 2012 Jan;1824(1):123-32. doi: 10.1016/j.bbapap.2011.07.025. Epub 2011 Aug 5. Review.


Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma.

Malla RR, Gopinath S, Gondi CS, Alapati K, Dinh DH, Gujrati M, Rao JS.

Cancer Gene Ther. 2011 Jun;18(6):419-34. doi: 10.1038/cgt.2011.9. Epub 2011 Mar 11.


Cathepsin B: a potential prognostic marker for inflammatory breast cancer.

Nouh MA, Mohamed MM, El-Shinawi M, Shaalan MA, Cavallo-Medved D, Khaled HM, Sloane BF.

J Transl Med. 2011 Jan 3;9:1. doi: 10.1186/1479-5876-9-1.


Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S.

PLoS One. 2010 Nov 3;5(11):e13831. doi: 10.1371/journal.pone.0013831.


Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.

Gopinath S, Malla RR, Gondi CS, Alapati K, Fassett D, Klopfenstein JD, Dinh DH, Gujrati M, Rao JS.

PLoS One. 2010 Jul 22;5(7):e11668. doi: 10.1371/journal.pone.0011668.


International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M.

Ann Oncol. 2011 Mar;22(3):515-23. doi: 10.1093/annonc/mdq345. Epub 2010 Jul 5.


Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.

Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD.

Cancer. 2010 Jun 1;116(11 Suppl):2768-82. doi: 10.1002/cncr.25181.


Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.

Nalla AK, Gorantla B, Gondi CS, Lakka SS, Rao JS.

Cancer Gene Ther. 2010 Sep;17(9):599-613. doi: 10.1038/cgt.2010.16. Epub 2010 May 7.


Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.

Venkitaraman R.

Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189. Review.


Triple negative breast cancers: clinical and prognostic implications.

Dawson SJ, Provenzano E, Caldas C.

Eur J Cancer. 2009 Sep;45 Suppl 1:27-40. doi: 10.1016/S0959-8049(09)70013-9. Review.


Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intravascular growth.

Vermeulen PB, Van Laere SJ, Dirix LY.

Br J Cancer. 2009 Sep 15;101(6):1028-9; author reply 1030. doi: 10.1038/sj.bjc.6605251. Epub 2009 Aug 25. No abstract available.


Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.

Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, Mercier I, Flomenberg N, Frank PG, Pestell RG, Lisanti MP.

Am J Pathol. 2009 May;174(5):1650-62. doi: 10.2353/ajpath.2009.080648.


Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation.

Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF.

Exp Cell Res. 2009 Apr 15;315(7):1234-46. doi: 10.1016/j.yexcr.2009.01.021. Epub 2009 Feb 3.


Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ.

Cancer Res. 2009 Mar 15;69(6):2260-8. doi: 10.1158/0008-5472.CAN-07-5575. Epub 2009 Mar 10.


Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.

Gillet L, Roger S, Besson P, Lecaille F, Gore J, Bougnoux P, Lalmanach G, Le Guennec JY.

J Biol Chem. 2009 Mar 27;284(13):8680-91. doi: 10.1074/jbc.M806891200. Epub 2009 Jan 28.


Imaging and quantifying the dynamics of tumor-associated proteolysis.

Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K, Mullins SR, Olive MB, Rudy D, Sloane BF.

Clin Exp Metastasis. 2009;26(4):299-309. doi: 10.1007/s10585-008-9218-7. Epub 2008 Dec 13. Review.


Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, Leung S, Wiseman SM, Nabi IR.

Cancer Res. 2008 Oct 15;68(20):8210-20. doi: 10.1158/0008-5472.CAN-08-0343.


Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.

Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, Powe D, Reis-Filho JS, Ellis IO.

Br J Cancer. 2008 Jul 22;99(2):327-34. doi: 10.1038/sj.bjc.6604463. Epub 2008 Jul 8.


Visualizing protease activity in living cells: from two dimensions to four dimensions.

Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF.

Curr Protoc Cell Biol. 2008 Jun;Chapter 4:Unit 4.20. doi: 10.1002/0471143030.cb0420s39.


Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.

Weigelt B, Bissell MJ.

Semin Cancer Biol. 2008 Oct;18(5):311-21. doi: 10.1016/j.semcancer.2008.03.013. Epub 2008 Mar 26. Review.

Supplemental Content

Support Center